Page All:
Page 1
QIAGEN Launches High-throughput Solutions for Human ID Databases
Partnering with Hamilton Robotics to deliver automated workflows for DNA fingerprinting
HILDEN, Germany and GERMANTOWN, Maryland, October 10, 2016 /PRNewswire/ --
QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced the launch
of automated high-throughput solutions, developed in partnership with Hamilton Robotics,
to serve the growing need for DNA fingerprinting of samples for human identity databases.
The streamlined automated workflows enable high-throughput assay setup for analyzing large
numbers of reference samples collected for law enforcement databases.
"QIAGEN is pleased to partner with Hamilton to launch complete, efficient solutions
for human identity workflows, especially to help increase capacity and relieve backlogs in
law enforcement database laboratories. This substantially broadens our presence in
forensics and human ID," said Dr. Thomas Schnibbe, Senior Director and Head of QIAGEN's
global forensics franchise. "Our Investigator(R) STR GO! Kits for amplification of short
tandem repeats (STRs) already provide fast, convenient processing of samples. The workflow
developed with Hamilton includes QIAGEN's new STAR Q instrument line for efficient
pre-treatment and assay setup, coupling robust chemistry with a streamlined process to
deliver speed, low unit cost and high quality. Furthermore the solution features QIAGEN's
new Quality Sensor, a novel internal performance control perfecting quality monitoring in
highly automated processes."
Click here
[https://www.qiagen.com/about-us/press-releases/pressreleaseview?ID=%7b9982FB1B-FF16-441D-9DE8-4C412656B5B8%7d&lang=en ]
for full press release
https://www.qiagen.com/about-us/press-releases/pressreleaseview?ID=
{9982FB1B-FF16-441D-9DE8-4C412656B5B8}&lang=en
[https://www.qiagen.com/about-us/press-releases/pressreleaseview?ID=%7b9982FB1B-FF16-441D-9DE8-4C412656B5B8%7d&lang=en ]
Â
ContactsÂ
Â
Public Relations:Â Â
Dr. Thomas TheuringerÂ
Senior Director Public RelationsÂ
+49-2103-29-11826Â
Email: pr@qiagen.com
Â
http://www.twitter.com/qiagenÂ
https://www.facebook.com/QIAGENÂ
pr.qiagen.com [https://www.qiagen.com/de/about-us ]
Â
Investor Relations:Â Â
John GilardiÂ
Vice President Corporate Communications and Investor RelationsÂ
+49-2103-29-11711Â
Email: ir@qiagen.com
Â
ir.qiagen.com [http://www.qiagen.com/About-Us/Investors ]
Â
Â
QIAGEN N.V.
QIAGEN Launches High-throughput Solutions for Human ID Databases
Partnering with Hamilton Robotics to deliver automated workflows for DNA fingerprinting
HILDEN, Germany and GERMANTOWN, Maryland, October 10, 2016 /PRNewswire/ --
QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced the launch
of automated high-throughput solutions, developed in partnership with Hamilton Robotics,
to serve the growing need for DNA fingerprinting of samples for human identity databases.
The streamlined automated workflows enable high-throughput assay setup for analyzing large
numbers of reference samples collected for law enforcement databases.
"QIAGEN is pleased to partner with Hamilton to launch complete, efficient solutions
for human identity workflows, especially to help increase capacity and relieve backlogs in
law enforcement database laboratories. This substantially broadens our presence in
forensics and human ID," said Dr. Thomas Schnibbe, Senior Director and Head of QIAGEN's
global forensics franchise. "Our Investigator(R) STR GO! Kits for amplification of short
tandem repeats (STRs) already provide fast, convenient processing of samples. The workflow
developed with Hamilton includes QIAGEN's new STAR Q instrument line for efficient
pre-treatment and assay setup, coupling robust chemistry with a streamlined process to
deliver speed, low unit cost and high quality. Furthermore the solution features QIAGEN's
new Quality Sensor, a novel internal performance control perfecting quality monitoring in
highly automated processes."
Click here
[https://www.qiagen.com/about-us/press-releases/pressreleaseview?ID=%7b9982FB1B-FF16-441D-9DE8-4C412656B5B8%7d&lang=en ]
for full press release
https://www.qiagen.com/about-us/press-releases/pressreleaseview?ID=
{9982FB1B-FF16-441D-9DE8-4C412656B5B8}&lang=en
[https://www.qiagen.com/about-us/press-releases/pressreleaseview?ID=%7b9982FB1B-FF16-441D-9DE8-4C412656B5B8%7d&lang=en ]
Â
ContactsÂ
Â
Public Relations:Â Â
Dr. Thomas TheuringerÂ
Senior Director Public RelationsÂ
+49-2103-29-11826Â
Email: pr@qiagen.com
Â
http://www.twitter.com/qiagenÂ
https://www.facebook.com/QIAGENÂ
pr.qiagen.com [https://www.qiagen.com/de/about-us ]
Â
Investor Relations:Â Â
John GilardiÂ
Vice President Corporate Communications and Investor RelationsÂ
+49-2103-29-11711Â
Email: ir@qiagen.com
Â
ir.qiagen.com [http://www.qiagen.com/About-Us/Investors ]
Â
Â
QIAGEN N.V.